Literature DB >> 19099274

[64-year old patient with tachycardia and signs of heart failure].

M M Zaruba1, T Waggershauser, S Weckbach, A Gerbes, O Mühling, S Kääb.   

Abstract

We report on a 64-year old patient with known Morbus Osler and high cardiac output failure due to distinct arterio-venous malformations of the liver. Since the patient suffered from severe right heart insufficiency despite optimized medical therapy, we decided to conduct an interventional occlusion of the hepatic shunts in three single sessions. The transient elevation of transaminases was reversible. After interventional therapy cardiac output decreased from 20 l/min to 15 l/min (25%) leading to a reduction of diuretic dosage and a sustained stabilization of the clinical condition.

Entities:  

Mesh:

Year:  2009        PMID: 19099274     DOI: 10.1007/s00108-008-2260-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

1.  Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement.

Authors:  O Boillot; F Bianco; J P Viale; F Mion; I Mechet; D Gille; J Delaye; P Paliard; H Plauchu
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

2.  Hereditary hemorrhagic telangiectases: magnetic resonance imaging features in liver involvement.

Authors:  Laurent Milot; Guillaume Gautier; Olivier Beuf; Frank Pilleul
Journal:  J Comput Assist Tomogr       Date:  2006 May-Jun       Impact factor: 1.826

Review 3.  Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations.

Authors:  Elisabetta Buscarini; Henry Plauchu; Guadalupe Garcia Tsao; Robert I White; Carlo Sabbà; Franklin Miller; Jean Cristophe Saurin; Jean Pierre Pelage; Gaetan Lesca; Marie Jeanne Marion; Annalisa Perna; Marie E Faughnan
Journal:  Liver Int       Date:  2006-11       Impact factor: 5.828

Review 4.  Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred.

Authors:  J E McDonald; F J Miller; S E Hallam; L Nelson; D A Marchuk; K J Ward
Journal:  Am J Med Genet       Date:  2000-08-14

5.  Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease).

Authors:  M Caselitz; S Wagner; A Chavan; M Gebel; J S Bleck; A Wu; H J Schlitt; M Galanski; M P Manns
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

6.  Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT).

Authors:  Martin Caselitz; Matthias J Bahr; Jörg S Bleck; Ajay Chavan; Michael P Manns; Siegfried Wagner; Michael Gebel
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

7.  Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations.

Authors:  Ajay Chavan; Martin Caselitz; Karl-Friedrich Gratz; Joachim Lotz; Timm Kirchhoff; Plinio Piso; Siegfried Wagner; Michael Manns; Michael Galanski
Journal:  Eur Radiol       Date:  2004-08-17       Impact factor: 5.315

8.  Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia -- results of extensive screening.

Authors:  E Buscarini; C Danesino; C Olivieri; G Lupinacci; F De Grazia; L Reduzzi; P Blotta; P Gazzaniga; F Pagella; M Grosso; G Pongiglione; L Buscarini; H Plauchu; A Zambelli
Journal:  Ultraschall Med       Date:  2004-09       Impact factor: 6.548

9.  Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement.

Authors:  Amato Antonio Stabile Ianora; Maurizio Memeo; Carlo Sabba; Anna Cirulli; Antonio Rotondo; Giuseppe Angelelli
Journal:  Radiology       Date:  2003-11-26       Impact factor: 11.105

10.  Screening family members of patients with hereditary hemorrhagic telangiectasia.

Authors:  T Haitjema; F Disch; T T Overtoom; C J Westermann; J W Lammers
Journal:  Am J Med       Date:  1995-11       Impact factor: 4.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.